0001209191-18-056084.txt : 20181024 0001209191-18-056084.hdr.sgml : 20181024 20181024172102 ACCESSION NUMBER: 0001209191-18-056084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181023 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLOSK STEVEN M CENTRAL INDEX KEY: 0001192621 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 181137086 MAIL ADDRESS: STREET 1: C/O CAMBREX CORP STREET 2: ONE MEADOWLANDS PLZ CITY: EAST RUTHERFORD STATE: NJ ZIP: 07073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-23 0 0000820081 CAMBREX CORP CBM 0001192621 KLOSK STEVEN M ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 1 1 0 0 President & CEO Common Stock 2018-10-23 4 M 0 20000 17.81 A 103328 D Common Stock 2018-10-23 4 S 0 16805 54.6659 D 86523 D Common Stock 2018-10-23 4 S 0 3195 55.2718 D 83328 D Stock Option (right to buy) 17.81 2018-10-23 4 M 0 20000 0.00 A 2021-10-22 Common Stock 20000 0 D The exercise of stock options and sale of corresponding shares reported herein was carried out pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.16 to $55.10 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.18 to $55.38 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4. The option representing a right to purchase 80,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted. Samantha Hanley for Steven Klosk by POA 2018-10-24